Paula D. Ryan

10.1k total citations · 1 hit paper
48 papers, 5.2k citations indexed

About

Paula D. Ryan is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Paula D. Ryan has authored 48 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 17 papers in Genetics and 17 papers in Cancer Research. Recurrent topics in Paula D. Ryan's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (12 papers) and BRCA gene mutations in cancer (11 papers). Paula D. Ryan is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (12 papers) and BRCA gene mutations in cancer (11 papers). Paula D. Ryan collaborates with scholars based in United States, Denmark and Israel. Paula D. Ryan's co-authors include Daniel A. Haber, Shyamala Maheswaran, Mehmet Toner, Lecia V. Sequist, Subba R. Digumarthy, Sunitha Nagrath, Ulysses J. Balis, Eunice L. Kwak, Daniel Irimia and Daphne W. Bell and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Paula D. Ryan

46 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of rare circulating tumour cells in cancer patients by microchip technology

2007 2.9k citations Sunitha Nagrath, Lecia V. Sequist et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula D. Ryan United States	21	3.0k	1.8k	1.6k	1.5k	799	48	5.2k
Marija Balić Austria	30	2.5k 0.8×	834 0.5×	1.6k 1.0×	1.0k 0.7×	737 0.9×	123	3.8k
Shannon L. Stott United States	31	4.9k 1.6×	3.2k 1.8×	3.1k 2.0×	2.6k 1.7×	1.1k 1.3×	62	8.3k
Andrew I. Minchinton Canada	30	1.4k 0.5×	1.4k 0.8×	1.1k 0.7×	2.0k 1.3×	604 0.8×	103	5.1k
David T. Ting United States	37	4.4k 1.5×	1.4k 0.8×	2.9k 1.8×	3.6k 2.3×	1.1k 1.4×	123	8.4k
Jeri Matera United States	9	6.3k 2.1×	2.1k 1.1×	4.3k 2.7×	1.6k 1.0×	2.2k 2.8×	16	8.1k
Daniel Shao-Weng Tan Singapore	34	2.5k 0.8×	1.2k 0.6×	1.0k 0.7×	1.5k 1.0×	2.0k 2.5×	173	4.8k
Brigitte Rack Germany	37	4.6k 1.5×	784 0.4×	3.7k 2.3×	1.9k 1.2×	1.5k 1.9×	218	6.6k
W. Jeffrey Allard United States	25	6.4k 2.1×	2.1k 1.1×	4.5k 2.9×	3.3k 2.2×	2.9k 3.7×	50	11.8k
Christian Schindlbeck Germany	30	3.0k 1.0×	585 0.3×	2.1k 1.3×	918 0.6×	912 1.1×	83	4.0k
François‐Clément Bidard France	47	5.0k 1.6×	945 0.5×	4.5k 2.9×	2.0k 1.3×	2.4k 3.0×	220	7.8k

Countries citing papers authored by Paula D. Ryan

Since Specialization

Citations

This map shows the geographic impact of Paula D. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula D. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula D. Ryan more than expected).

Fields of papers citing papers by Paula D. Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula D. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula D. Ryan. The network helps show where Paula D. Ryan may publish in the future.

Co-authorship network of co-authors of Paula D. Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Paula D. Ryan. A scholar is included among the top collaborators of Paula D. Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula D. Ryan. Paula D. Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayer, Erica L., Nabihah Tayob, Siyang Ren, et al.. (2023). A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer. Breast Cancer Research and Treatment. 204(1). 123–132. 5 indexed citations

Bardia, Aditya, Laura M. Spring, Dejan Juric, et al.. (2020). 358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer. Annals of Oncology. 31. S394–S394. 5 indexed citations

Birkbak, Nicolai J., Y. Li, Shailja Pathania, et al.. (2018). Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. Annals of Oncology. 29(4). 903–909. 47 indexed citations

Fan, Lei, Pedro Emanuel Rubini Liedke, Steven J. Isakoff, et al.. (2013). Intermittent Letrozole Therapy for Metastatic Breast Cancer: Case Reports and Literature Review. Clinical Breast Cancer. 14(2). e41–e45.

Birkbak, Nicolai J., Zhigang C. Wang, Ji-Young Kim, et al.. (2012). Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents. Cancer Discovery. 2(4). 366–375. 412 indexed citations

Jain, Angela, Paula D. Ryan, & Michael V. Seiden. (2012). Metastatic Mucinous Ovarian Cancer and Treatment Decisions Based on Histology and Molecular Markers Rather Than the Primary Location. Journal of the National Comprehensive Cancer Network. 10(9). 1076–1080. 23 indexed citations

Shannon, Kristen M., et al.. (2011). Which individuals undergoing BRACAnalysis need BART testing?. Cancer Genetics. 204(8). 416–422. 6 indexed citations

Lowry, Kathryn P., Janie M. Lee, Chung Yin Kong, et al.. (2011). Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers. Cancer. 118(8). 2021–2030. 76 indexed citations

Golshan, Mehra, Judy E. Garber, Rebecca Gelman, et al.. (2010). Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?. Annals of Surgical Oncology. 18(3). 733–737. 26 indexed citations

10.

Lee, Janie M., Pamela M. McMahon, Chung Yin Kong, et al.. (2010). Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for ScreeningBRCA1Gene Mutation Carriers. Radiology. 254(3). 793–800. 54 indexed citations

11.

Wittner, Ben S., Dennis C. Sgroi, Paula D. Ryan, et al.. (2008). Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort. Clinical Cancer Research. 14(10). 2988–2993. 115 indexed citations

12.

Eichler, April F., Irene Kuter, Paula D. Ryan, et al.. (2008). Survival in patients with brain metastases from breast cancer. Cancer. 112(11). 2359–2367. 130 indexed citations

13.

Lee, Janie M., Daniel B. Kopans, Pamela M. McMahon, et al.. (2008). Breast Cancer Screening inBRCA1Mutation Carriers: Effectiveness of MR Imaging—Markov Monte Carlo Decision Analysis. Radiology. 246(3). 763–771. 34 indexed citations

14.

Harris, Lyndsay N., Fanglei You, Stuart J. Schnitt, et al.. (2007). Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer. Clinical Cancer Research. 13(4). 1198–1207. 190 indexed citations

15.

Nagrath, Sunitha, Lecia V. Sequist, Shyamala Maheswaran, et al.. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 450(7173). 1235–1239. 2908 indexed citations breakdown →

16.

Shannon, Kristen M., et al.. (2006). Uptake of BRCA1 rearrangement panel testing: In individuals previously tested for BRCA1/2 mutations. Genetics in Medicine. 8(12). 740–745. 1 indexed citations

17.

Ryan, Paula D. & Paul E. Goss. (2005). The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer. Nature Clinical Practice Oncology. 2(12). 596–597. 2 indexed citations

18.

Ryan, Paula D., Daniel B. Kopans, & Dennis C. Sgroi. (2005). Case 24-2005. New England Journal of Medicine. 353(6). 617–622.

19.

Ryan, Paula D., et al.. (2003). Case 28-2003. New England Journal of Medicine. 349(11). 1076–1082. 2 indexed citations

20.

Burstein, Harold J., Lyndsay N. Harris, P. Kelly Marcom, et al.. (2003). Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm. Journal of Clinical Oncology. 21(15). 2889–2895. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact